相关实验视频

Updated: Jun 24, 2025

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

使用TYK2抑制剂修改T细胞表型及其对全身性红斑狼治疗的影响

Yurie Satoh-Kanda¹, Shingo Nakayamada¹, Satoshi Kubo^1,2

¹The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Fukuoka, Japan.

|June 13, 2024

概括

JAK/TYK2抑制剂对系统性红斑狼 (SLE) 中的T毛囊辅助 (Tfh) 和T调节 (Treg) 细胞平衡产生影响. 通过选择性调节Tfh1和Treg细胞分化,TYK2抑制剂在恢复免疫平衡方面表现有前途.

科学领域:

免疫学免疫学免疫学
分子生物学分子生物学
类风湿病学类风湿病学

背景情况:

系统性红斑狼 (SLE) 具有免疫失调的特征,包括T毛囊辅助细胞 (Tfh) 和T调控细胞 (Treg) 之间的不平衡.
Tfh细胞,特别是Tfh1亚型,通过它们对B细胞分化的影响,与SLE病变有关.

研究的目的:

研究Janus激酶 (JAK) 和TYK2抑制剂对SLE中Tfh/Treg细胞失衡的影响.
探索TYK2抑制在调节与SLE相关的免疫反应中的潜力.

主要方法:

来自SLE患者和健康对照的外周血液单核细胞的分析.
在狼性炎组织上进行免疫组织化学检测,以识别Tfh1细胞透.
试验室共培养试验评估Tfh1细胞对B细胞分化的影响.
JAK/TYK2-依赖的STAT酸化试验,以评估抑制剂对T细胞信号通路的影响.

主要成果:

在SLE患者中观察到Tfh1细胞数量的增加和激活Treg细胞数量的减少,特别是在活跃的狼性炎患者中.
从健康个体中分离出来的Tfh1细胞促进了T-bet+B细胞的分化.
无论是JAK还是TYK2抑制剂都抑制了IL-12诱导的Tfh1细胞分化.
与其他JAK抑制剂不同,TYK2抑制剂没有抑制IL-2-诱导的Treg细胞分化.

结论:

通过诱导T-bet+B细胞的产生,Tfh1细胞有助于SLE的发病.
TYK2抑制剂可以通过选择性抑制Tfh1分化,同时保持Treg细胞功能,为SLE提供治疗策略.
准TYK2可以通过维持对Treg细胞至关重要的IL-2信号通路来微调SLE中的免疫反应.

关键词:

这是T-淋巴细胞.细胞因子细胞因子系统性红血性狼 (Systemic Lupus Erythematosus) 是一种全身性狼.

更多相关视频

Mouse Naïve CD4+ T Cell Isolation and In vitro Differentiation into T Cell Subsets

Mouse Naïve CD4+ T Cell Isolation and In vitro Differentiation into T Cell Subsets

Published on: April 16, 2015

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice

Published on: June 22, 2016

相关概念视频

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.